227958-72-7 Usage
Chemical class
Thiadiazole derivatives
Explanation
The compound belongs to a group of chemical compounds that contain a thiadiazole ring.
Explanation
The compound is derived from 5-amino-1,3,4-thiadiazole-2-propanoic acid by attaching a methyl ester group to it.
Explanation
The compound is used as a starting material or intermediate in the synthesis of various pharmaceutical compounds.
Explanation
Due to its unique structure and properties, the compound has the potential to interact with biological targets and influence various biological processes.
Explanation
The compound may be used in the development of novel drugs and therapeutic agents for the treatment of various diseases and conditions.
Explanation
The compound's bioactivity and potential pharmaceutical applications suggest that it could be used in the treatment of a range of diseases and conditions, although specific applications are not mentioned in the provided material.
Structure
Methyl ester of 5-amino-1,3,4-thiadiazole-2-propanoic acid
Application
Synthetic building block in medicinal chemistry and drug discovery
Pharmaceutical potential
Bioactive molecule in biological processes
Use in drug development
Development of new drugs and therapeutic agents
Potential therapeutic applications
Treatment of various diseases and conditions
Check Digit Verification of cas no
The CAS Registry Mumber 227958-72-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,7,9,5 and 8 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 227958-72:
(8*2)+(7*2)+(6*7)+(5*9)+(4*5)+(3*8)+(2*7)+(1*2)=177
177 % 10 = 7
So 227958-72-7 is a valid CAS Registry Number.
227958-72-7Relevant academic research and scientific papers
INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE
-
Page 63-64, (2008/06/13)
Compounds of formula (I) in free or salt form, wherein R1, R2, R3, and R4 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by mediated by phosphatidylinos
